FRIDAY, Jan. 6, 2023 (HealthDay News) — Patients with an incurable, genetic liver disease have new hope after an animal study showed that a single drug could reverse its effects. Alagille syndrome is caused by a mutation that prevents the formation and regeneration of bile ducts in the liver. AboutContinue Reading

WEDNESDAY, Dec. 14, 2022 (HealthDay News) — More than 155,000 people who have taken part in a massive genetic study orchestrated by the U.S. National Institutes of Health (NIH) have already gotten something in return — personalized DNA results that tell them whether they have an increased risk for certainContinue Reading

WEDNESDAY, Dec. 14, 2022 (HealthDay News) — For some people, dozens of U.S.-approved drugs can lead to a rare but often fatal brain infection. Researchers have now confirmed a strong link between four genetic mutations and this illness, called progressive multifocal leukoencephalopathy (PML). A new study found that in peopleContinue Reading

FRIDAY, Dec. 9, 2022 (HealthDay News) — A new genetic test may help determine which people with breast cancer can safely skip radiation after breast-conserving surgery to remove their tumor. Individuals with invasive breast cancer who had low scores on an investigational gene panel were just as likely to experienceContinue Reading

FRIDAY, Dec. 9, 2022 (HealthDay News) — One might expect identical twins to have the same health outcomes. But it’s not just genetics that makes a notable difference in their weight and in how their genes behave, according to a new study. Exercise can alter genetic markers of metabolic diseaseContinue Reading

THURSDAY, Nov. 10, 2022 (HealthDay News) – Doctors are hopeful that an innovative treatment performed before birth may help children born with the rare genetic, and often fatal, condition called Pompe disease. A thriving Canadian toddler is evidence that treatment while still in the womb offers better outcomes. Doctors fromContinue Reading

THURSDAY, Nov. 10, 2022 (HealthDay News) — Gene editing has for the first time produced modified immune cells finely honed to target and attack cancer cells, researchers say. A team used the gene editing tool CRISPR to alter immune cells drawn from 16 patients who had a variety of solidContinue Reading